LEVETIRACETAM DEXCEL 500

Држава: Израел

Језик: Енглески

Извор: Ministry of Health

Активни састојак:

LEVETIRACETAM

Доступно од:

DEXCEL PHARMA TECHNOLOGIES LTD

АТЦ код:

N03AX14

Фармацеутски облик:

TABLETS

Састав:

LEVETIRACETAM 500 MG

Пут администрације:

PER OS

Тип рецептора:

Required

Произведен од:

DEXCEL LTD, ISRAEL

Терапеутска група:

LEVETIRACETAM

Терапеутска област:

LEVETIRACETAM

Терапеутске индикације:

Levetiracetam Dexcel is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.Levetiracetam Dexcel is indicated as adjunctive therapy:• In the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.• In the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.• In the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy.

Датум одобрења:

2018-03-31